会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • Novel heteroaryl phosphonates as cardioprotective agents
    • 新型杂芳基膦酸酯作为心脏保护剂
    • US20040186077A1
    • 2004-09-23
    • US10391056
    • 2003-03-17
    • Medicure International Inc.
    • James DiakurWasimul HaqueWenlian ZhangJunzhi YaoVinh Pham
    • A61K031/675A61K031/44
    • C07F9/58
    • The invention teaches compound of general formula: 1 Wherein: R1 is selected from H and CH3, and R2 is selected from H and OH, or R1 and R2 together form an optionally substituted phenyl ring which is fused to the pyridine ring; and R3 is selected from H, CH3, CH2OH and 2 R4 is selected from H, CH3, CH2OH, 3 R5 is selected from H, phenyl, halogen-substituted phenyl and 4 Wherein R6 and R7 are each independently selected from H, Nanull, Knull, alkyl and optionally substituted aryl, and X and Y are each independently selected from H, OH and F, or at least one of X and Y is an heteroatom and together with R3 forms a bridge with the proviso that R4 is 5 and N-oxides thereof, and biologically acceptable salts thereof, related compounds, related pharmaceutical compositions, and methods for treating various disorders using such compositions.
    • 本发明教导了通式为的化合物:其中R1选自H和CH3,R2选自H和OH,或R1和R2一起形成与吡啶环稠合的任意取代的苯环; 并且R 3选自H,CH 3,CH 2 OH和R 4选自H,CH 3,CH 2 OH,R 5选自H,苯基,卤素取代的苯基,其中R 6和R 7各自独立地选自H, K +,烷基和任选取代的芳基,X和Y各自独立地选自H,OH和F,或者X和Y中的至少一个是杂原子,并且与R3一起形成桥,条件是R4是 其N-氧化物及其生物可接受的盐,相关化合物,相关药物组合物,以及使用这些组合物治疗各种病症的方法。